Sustained Drug Free Remission of Lupus Panniculitis with Methotrexate: A Case Report From Nepal

Authors

  • Binit Vaidya Department of Rheumatology, National Center for Rheumatic Diseases, Kathmandu, Nepal http://orcid.org/0000-0002-4840-8924
  • Rikesh Baral Department of Rheumatology, National Center for Rheumatic Diseases, Kathmandu, Nepal
  • Hritu Baral Department of Rheumatology, National Center for Rheumatic Diseases, Kathmandu, Nepal
  • Shweta Nakarmi Department of Rheumatology, National Center for Rheumatic Diseases, Kathmandu, Nepal

DOI:

https://doi.org/10.31729/jnma.3885

Keywords:

lupus; panniculitis; Nepal; Methotrexate

Abstract

Cutaneous manifestations are second most common presenting feature of lupus. Discoid lupus erythematosus is the most common variant amongst all; lupus panniculitis being described in only 2-5% of cases. Most cases of cutaneous lupus are associated with autoantibodies and either precede or follow the systemic manifestations of lupus. There is no proven treatment for cutaneous manifestations of lupus including lupus panniculitis. Available non-randomized studies show efficacy of hydroxychoroquine in most cases, whereas methotrexate and other immunosuppressant are used in relapsing cases.

We describe a case of lupus panniculitis presenting as an isolated manifestation of lupus with negative autoantibody titers which responded well to methotrexate. We observed that lesions went into drug-free remission in 1year and did not recur on 1year follow-up. There was no residual skin atrophy or scarring. Drug-free remission in isolated cases of lupus panniculitis variant could be possible with timely intervention in the absence of autoantibodies

Downloads

Published

2018-12-31

How to Cite

Vaidya, B., Baral, R., Baral, H., & Nakarmi, S. (2018). Sustained Drug Free Remission of Lupus Panniculitis with Methotrexate: A Case Report From Nepal. Journal of Nepal Medical Association, 56(214), 963–966. https://doi.org/10.31729/jnma.3885

Issue

Vol. 56 No. 214 (2018)

Section

Case Reports

License

JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.